Comparison of 18F-rhPSMA-7.3 PET/CT With and Without Furosemide in Biochemical Recurrence of Prostate Cancer

NCT05779943 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Prostate Adenocarcinoma
Recurrent Prostate Carcinoma

Interventions

DRUG: Furosemide
OTHER: F18-rhPSMA-7.3
PROCEDURE: Positron Emission Tomography
PROCEDURE: Computed Tomography

Sponsor

Emory University

Collaborators

[object Object]
[object Object]